Colgate

Feb 21, 2024

Shares of Colgate-Palmolive (NYSE:CL - Get Free Report) have been given an average recommendation of "Moderate Buy" by the eleven brokerages that are presently covering the firm, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average twelve-month price target among analysts that have issued a report on the stock in the last year is $85.33.

Several equities analysts have weighed in on CL shares. Wells Fargo & Company raised their target price on shares of Colgate-Palmolive from $76.00 to $81.00 in a report on Monday, May 1st. StockNews.com raised shares of Colgate-Palmolive from a "hold" rating to a "buy" rating in a research report on Monday, July 31st. Barclays boosted their target price on shares of Colgate-Palmolive from $77.00 to $81.00 and gave the stock an "equal weight" rating in a research report on Tuesday, August 1st. Royal Bank of Canada reissued a "sector perform" rating and set a $83.00 target price on shares of Colgate-Palmolive in a research report on Monday, July 31st. Finally, Bank of America upped their price target on shares of Colgate-Palmolive from $80.00 to $85.00 in a report on Monday, May 1st.

In related news, insider Prabha Parameswaran sold 64,373 shares of the company's stock in a transaction on Monday, May 8th. The shares were sold at an average price of $80.58, for a total value of $5,187,176.34. Following the completion of the sale, the insider now directly owns 12,427 shares in the company, valued at $1,001,367.66. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other Colgate-Palmolive news, Director John P. Bilbrey sold 5,703 shares of the firm's stock in a transaction on Tuesday, May 9th. The shares were sold at an average price of $80.81, for a total value of $460,859.43. Following the sale, the director now directly owns 26,257 shares in the company, valued at approximately $2,121,828.17. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Prabha Parameswaran sold 64,373 shares of the firm's stock in a transaction on Monday, May 8th. The stock was sold at an average price of $80.58, for a total transaction of $5,187,176.34. Following the completion of the sale, the insider now owns 12,427 shares in the company, valued at $1,001,367.66. The disclosure for this sale can be found here. Insiders have sold a total of 180,154 shares of company stock worth $14,444,585 in the last 90 days. 0.34% of the stock is owned by insiders.

A number of hedge funds and other institutional investors have recently made changes to their positions in CL. Tucker Asset Management LLC bought a new position in Colgate-Palmolive during the 1st quarter valued at about $27,000. Register Financial Advisors LLC bought a new position in Colgate-Palmolive during the 1st quarter valued at about $30,000. Capital Advisors Ltd. LLC lifted its holdings in Colgate-Palmolive by 36.4% during the 4th quarter. Capital Advisors Ltd. LLC now owns 704 shares of the company's stock valued at $33,000 after purchasing an additional 188 shares during the last quarter. WFA of San Diego LLC bought a new position in Colgate-Palmolive during the 4th quarter valued at about $35,000. Finally, Glass Jacobson Investment Advisors llc bought a new position in Colgate-Palmolive during the 2nd quarter valued at about $36,000. 79.01% of the stock is owned by institutional investors.

Shares of NYSE:CL opened at $76.26 on Friday. Colgate-Palmolive has a 52 week low of $67.84 and a 52 week high of $83.81. The company's 50 day moving average is $76.40 and its two-hundred day moving average is $75.83. The company has a current ratio of 1.17, a quick ratio of 0.25 and a debt-to-equity ratio of 28.43. The company has a market cap of $63.04 billion, a PE ratio of 42.37, a P/E/G ratio of 3.26 and a beta of 0.49.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings data on Friday, July 28th. The company reported $0.77 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.75 by $0.02. Colgate-Palmolive had a net margin of 8.02% and a return on equity of 386.76%. The company had revenue of $4.82 billion for the quarter, compared to the consensus estimate of $4.70 billion. During the same period last year, the firm posted $0.72 EPS. Colgate-Palmolive's revenue for the quarter was up 7.5% on a year-over-year basis. Equities analysts predict that Colgate-Palmolive will post 3.16 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, August 15th. Stockholders of record on Friday, July 21st will be paid a dividend of $0.48 per share. This represents a $1.92 dividend on an annualized basis and a dividend yield of 2.52%. The ex-dividend date is Thursday, July 20th. Colgate-Palmolive's dividend payout ratio (DPR) is presently 106.67%.

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.